Solara Active Pharma Sciences Ltd - Financial Result for the Quarter ended 30th Sep'26
Solara Active Pharma Sciences Ltd · Outcome · 16 Oct 2026, 7:06 pm
Solara Active Pharma Sciences Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Crore) ■ Revenue: 417 (+33.1% YoY | +9.4% QoQ) ■ EBITDA: 76.8 (+121.2% YoY | +24.0% QoQ) ■ EBITDA Margin (%): 18.4 (+734 bps YoY | +217 bps QoQ) ■ PAT: 28.5 (Loss to Profit YoY | +74.5% QoQ) ■ EPS (INR): 5.92 (Loss to Profit YoY | +68.2% QoQ)
Original exchange filing (PDF)
More announcements from Solara Active Pharma Sciences Ltd
- Transcript of Earnings Conference call pertaining to financial results of the Company for the quarter ended September 30, 2026 · 23 Oct 2026
- Solara Active Pharma Sciences Limited has informed the Exchange regarding the dispatch of Final Reminder -cum-Forfeiture Notice for the payment of outstanding call money to the holders .... · 18 Oct 2026
- Monitoring Agency Report for the quarter ended September 30, 2026 · 17 Oct 2026
- Audio recordings of Q2 FY27 earnings call conducted on October 16, 2026, for the quarter ended September 30, 2026 · 17 Oct 2026
- Solara Active Pharma Sciences Limited has informed the exchange about the Statement of Deviation/Variation in utilization of funds raised though Rights issue for the quarter ended September 30 2026 · 16 Oct 2026
- Solara Active Pharma Sciences Limited has informed the Exchange regarding grant of 470000 options under Solara Employee Stock Option Plan 2024 · 16 Oct 2026
- Solara Active Pharma Sciences Limited has informed the Exchange regarding a Press Release dated October 16, 2026, titled "Solara''s Q2 FY 27 revenue grows 33% to INR 4,178 Mn and EBITDA .... · 16 Oct 2026
- Solara Active Pharma Sciences Limited has informed the Exchange regarding allotment of 8,300 Equity shares pursuant to exercise of ESOP options. · 16 Oct 2026
